Recommendations for Pain Management in Cancer Patients

Pallav Dave
{"title":"Recommendations for Pain Management in Cancer Patients","authors":"Pallav Dave","doi":"10.22270/ajprd.v12i2.1339","DOIUrl":null,"url":null,"abstract":"Pain is a symptom that is reported in cancer patients with the prevalence varying from 33% to 64%. Addressing pain remains a critical aspect of cancer treatment with research showing that pain management in this population remains inadequate. Addressing pain is instrumental because of the impact it has on a patient’s life. It affects clinical outcomes, contributes to poor quality of life, and leads to psychological distress. Barriers remain the key challenge that contributes to inadequate management. Addressing these barriers can lead to better outcomes. Carrying out a comprehensive patient assessment and screening is recommended before beginning pain management. Pain is multidimensional in nature and for many patients, different factors may be contributing to pain. Conducting a comprehensive assessment helps to identify these factors. Comprehensive assessment also helps to capture important information that can contribute to better pain management. After conducting an assessment, pain management should begin. Cancer pain can be managed using pharmacological and non-pharmacological interventions. The interventions should aim to improve patient comfort and function. The interventions should also provide more benefits than adverse effects. One of the mainstay interventions in managing cancer pain is opioids. Opioids should be given in accordance with recommendations from different guidelines to ensure they are effective.\n \n ","PeriodicalId":8526,"journal":{"name":"Asian Journal of Pharmaceutical Research and Development","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutical Research and Development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22270/ajprd.v12i2.1339","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Pain is a symptom that is reported in cancer patients with the prevalence varying from 33% to 64%. Addressing pain remains a critical aspect of cancer treatment with research showing that pain management in this population remains inadequate. Addressing pain is instrumental because of the impact it has on a patient’s life. It affects clinical outcomes, contributes to poor quality of life, and leads to psychological distress. Barriers remain the key challenge that contributes to inadequate management. Addressing these barriers can lead to better outcomes. Carrying out a comprehensive patient assessment and screening is recommended before beginning pain management. Pain is multidimensional in nature and for many patients, different factors may be contributing to pain. Conducting a comprehensive assessment helps to identify these factors. Comprehensive assessment also helps to capture important information that can contribute to better pain management. After conducting an assessment, pain management should begin. Cancer pain can be managed using pharmacological and non-pharmacological interventions. The interventions should aim to improve patient comfort and function. The interventions should also provide more benefits than adverse effects. One of the mainstay interventions in managing cancer pain is opioids. Opioids should be given in accordance with recommendations from different guidelines to ensure they are effective.    
癌症患者疼痛管理建议
疼痛是癌症患者的一种症状,发病率从 33% 到 64% 不等。研究表明,癌症患者的疼痛管理仍然不足。解决疼痛问题至关重要,因为疼痛会影响患者的生活。疼痛会影响临床效果,导致生活质量低下,并造成心理困扰。障碍仍然是导致管理不足的主要挑战。消除这些障碍可以取得更好的疗效。建议在开始疼痛治疗前对患者进行全面的评估和筛查。疼痛的本质是多方面的,对许多患者来说,不同的因素可能会导致疼痛。进行全面评估有助于确定这些因素。全面评估还有助于获取有助于更好地进行疼痛管理的重要信息。进行评估后,应开始疼痛管理。可以通过药物和非药物干预来控制癌痛。干预措施应旨在改善患者的舒适度和功能。干预措施的益处也应大于不良反应。阿片类药物是控制癌痛的主要干预措施之一。阿片类药物的使用应遵循不同指南的建议,以确保其有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信